WO2014094101A1 - Ingrediente protetor da barreira cutânea e formulação cosmética e/ou dermatológica contendo o mesmo - Google Patents
Ingrediente protetor da barreira cutânea e formulação cosmética e/ou dermatológica contendo o mesmo Download PDFInfo
- Publication number
- WO2014094101A1 WO2014094101A1 PCT/BR2013/000590 BR2013000590W WO2014094101A1 WO 2014094101 A1 WO2014094101 A1 WO 2014094101A1 BR 2013000590 W BR2013000590 W BR 2013000590W WO 2014094101 A1 WO2014094101 A1 WO 2014094101A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cosmetic
- dermatological
- skin barrier
- skin
- protective ingredient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
- A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
- A61Q1/06—Lipsticks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Definitions
- the present invention relates to ingredients for cosmetic and / or dermatological products in general, more specifically to a skin barrier protective ingredient and cosmetic and / or dermatological formulation containing the same which, according to its general characteristics, has as a principle basic to provide a skin barrier protective ingredient from a fraction derived from liposome-incorporated Malus sp apple extract (soy lecithin) at specific concentrations with a view to providing this fraction of the liposomal Malus sp apple extract with a differentiated hydrating activity It provides protection to the skin and minimizes the signs of aging through actions of reinforcement and improvement of the skin barrier function, induction of epidermal cell proliferation and differentiation (keratinocytes), development of the epidermis, regulation of cell development and differentiation, favoring circulation. bloody and activation of cutaneous ceramide metabolism.
- telomeres are shortened to a critical length, when cell proliferation can be stopped and the cell goes into senescence or aging.
- tissue regenerative potential is a major cause of aging. Since an organism's regenerative process is determined by its proliferative capacity, aging is directly dependent on the ability of skin cells to proliferate. Additionally, cell renewal is a mechanism known to maintain skin homeostasis involving keratinocyte proliferation and differentiation. With aging, the regenerative capacity of the skin decreases. Thus, stimulating keratinocyte proliferation represents an approach of wide interest for the treatment of skin aging, promoting skin barrier reinforcement. In this context, it has become essential to structure an active for skin application in different types of products, such as soaps, shampoos, lipsticks and makeup in general, sunscreens, creams and lotions, indicated primarily for the protection of barrier function. minimizing some of the main signs of aging, that is, allowing the origin of various types of cosmetic and / or dermatological products with proven application, constituting an innovative option for human skin treatment.
- apple extracts have been widely applied in cosmetic and dermatological products of the skin care and makeup categories such as creams, lotions, soaps, serum, shampoos and sunscreens among many others.
- Malus domestica apple species is widely known in the art for its excellent longevity and ability to remain stable over time.
- the apple tree of Swiss origin known by the name of Uttwiler Nolauber, were removed several portions of tissue, in order to obtain plant tissue cultures that allow extensive studies of its composition and properties.
- French Patent Document FR2916972 comprises the combination of apple extract, apple cider vinegar, almond glycoproteins, silicone and at least one essential oil.
- the composition and cosmetic products containing said combination are exclusively intended to inhibit the action of metalloproteinases, thus preventing the degradation of elastin fibers present in the dermal matrix, which departs from the object claimed in the present patent by constituting a differentiated combination of ingredients with the apple extract.
- US20070036742 comprises the combination of extracts from one or more of the following plants: Boswellia Serrata, Undaria Pinnatifida, Green Tea, Pureraria Mirifica, Luteoline, Astilbine, Vitamin E, Amentoflavone, Tetrahydropiperine, Lychalcone, Astaxanthin, Red Clover, Brassica Juncea, CoQ10 enzyme, sage, shikimic acid, hop oil-resin, apple, soybean, ellagic acid, or any derivative thereof.
- the composition and cosmetic products containing said combination are intended solely to modulate the growth or regrowth of human hair.
- the present patent is characterized by bringing together components in a differentiated design, which will meet the various requirements that the nature of use demands, that is, to confer wide improvement of the skin barrier function that provides protection to the skin and minimizes some of the main signs of aging, besides acting in the increase of the metabolism of the lipids.
- This design guarantees an efficient and reliable skin barrier protective ingredient due to its aggregate technical qualities, which provides advantages and improvements in maintaining the overall balance of human skin.
- the present protective ingredient of the skin barrier and the cosmetic and / or dermatological formulation containing it is based on a fraction from Malus sp apple extract, of Swiss origin, capable of acting directly on specific cellular and tissue mechanisms related to the skin. aging of the human skin, thus ensuring a broad anti-aging activity and perfect protection of the skin barrier function.
- a fraction from Malus sp extract consisting of arabinose, mannose, galactose and inositol at defined concentrations was obtained by specific filtration processes, and this fraction was incorporated into a phospholipid liposome concentrate of soybean (lecithin) in order to make it liposome, ie protected by layers of phospholipids that allow its controlled release.
- this fraction is closely related to actions of induction of cell proliferation and improvement of skin barrier function, besides acting on the increase of lipid metabolism, that is, the provision of a composition containing a fraction obtained at from Malus domestica able to act in various cellular and tissue mechanisms of human skin, besides having high stability when applied in cosmetic and / or dermatological formulations.
- the present "Skin Barrier Protective Ingredient and Cosmetic and / or Dermatological Formulation Containing the Same” is comprised of a set of correctly incorporated cosmetic and / or dermatological solutions constituting a basic formulation skin barrier protective ingredient. consistent with differentiated final qualities which, by their own characteristics, is obtained from a fraction from Malus sp apple extract consisting of arabinose, mannose, galactose and inositol in concentrations defined by specific filtration processes and incorporated to a soybean phospholipid-derived liposome concentrate (lecithin) making it liposome, the formulation and, therefore, the amounts employed, based directly on the intended applications in order to obtain an excellent barrier protective ingredient that provides a broad and effective overall skin balance and attenuation of aging by various cosmetic and / or dermatological formulations.
- Skin Barrier Protective Ingredient and Cosmetic and / or Dermatological Formulation Containing the Same is comprised of cosmetic and / or dermatological formulations in which its basic formulations consist of a range of approximately one hundred percent to ten percent by weight of the ingredient. skin barrier protector.
- the "Skin Barrier Protective Ingredient and Cosmetic and / or Dermatological Formulation Containing the Same” is understood to be cosmetic and / or dermatological formulations where said skin barrier protective ingredient may eventually be added and may include constituent ingredients of the base of the composition or other ingredients.
- active or functional ingredients such as surfactants, humectants, thickeners, fragrances, preservatives, sequestrants, sunscreens, essences, dyes, emulsifiers, active ingredients, sensory modifiers among others.
- the cytotoxicity of the apple extract fraction was investigated using the MTS (a tetrazolic compound) technique and the evaluation of cell death mechanism by flow cytometry by quantifying specific protein markers. These tests indicated absence of cytotoxicity in human dermal fibroblasts to the maximum concentration tested, in addition to the absence of significant mechanisms of apoptosis or necrosis at the evaluated concentrations. Thus, the absence of cytotoxicity-related processes for this fraction of apple extract was evidenced.
- the effectiveness of the apple extract fraction on keratinocyte proliferation was investigated using the technique of evaluating the rate of keratinocyte proliferation in cell culture after forty-eight hours in the presence or absence of the apple extract fraction. . Also, the proliferative capacity in reconstituted skin was evaluated up to twenty-one days to visualize the number of layers of the epidermis. Results from biological tests showed that the apple extract fraction induced a significant increase in keratinocyte proliferation by about 40 percent. In the reconstituted skin, the condition submitted to this fraction increased from 15 ⁇ 2 to 20 ⁇ 2 epidermal layers.
- cosmetic and / or dermatological formulations containing the skin barrier protective ingredient object of the present invention are the cosmetic and / or dermatological formulations of skin barrier protective bases for lipstick or makeup in general, soap liquid, face / body cream / protector and makeup foundation through from the tables detailed below, in which the components are combined and the quantities represented as a percentage by weight, based on the total weight of the composition.
- Humectants Polyethylene glycols 0.5 - 2.5%
- Humectants Polyethylene glycols 0.5 - 2.5%
- Humectants Polyethylene glycols 0.5 - 10%
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/653,664 US20150306010A1 (en) | 2012-12-21 | 2013-12-20 | Protective ingredient of skin barrier and cosmetic and/or dermatologic formulation containing the same |
EP13865534.5A EP2937075A4 (en) | 2012-12-21 | 2013-12-20 | PROTECTIVE SKIN BARRIER COMPONENT AND COSMETIC AND / OR DERMATOLOGICAL FORMULATION THEREWITH |
JP2015548116A JP2016503034A (ja) | 2012-12-21 | 2013-12-20 | 皮膚保護剤の保護成分並びにそれを含む化粧用及び/又は皮膚科用製剤 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR102012032898-4A BR102012032898B1 (pt) | 2012-12-21 | 2012-12-21 | Ingrediente protetor da barreira cutânea e formulação cosmética e/ou dermatológica contendo o mesmo |
BRBR1020120328984 | 2012-12-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014094101A1 true WO2014094101A1 (pt) | 2014-06-26 |
Family
ID=50977440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/BR2013/000590 WO2014094101A1 (pt) | 2012-12-21 | 2013-12-20 | Ingrediente protetor da barreira cutânea e formulação cosmética e/ou dermatológica contendo o mesmo |
Country Status (4)
Country | Link |
---|---|
US (1) | US20150306010A1 (pt) |
JP (1) | JP2016503034A (pt) |
BR (1) | BR102012032898B1 (pt) |
WO (1) | WO2014094101A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3048253A1 (en) * | 2016-12-30 | 2018-07-05 | Skinprotect Corporation Sdn Bhd | Elastomeric articles having skin care properties and methods for their production |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2808442A1 (fr) * | 2000-05-04 | 2001-11-09 | Silab Sa | Procede d'extraction d'un principe actif a partir de teguments de pomme, principe actif obtenu et composition adaptee pour lutter contre les consequences du stress oxydatif de la peau |
US20070036742A1 (en) | 2005-08-09 | 2007-02-15 | Access Business Group International Llc | Methods and compositions for modulating hair growth or regrowth |
FR2916972A1 (fr) | 2007-06-07 | 2008-12-12 | Occitane Sa L | Composition cosmetique ou dermatologique a base de pomme et son utilisation. |
US20120195948A1 (en) * | 2007-04-27 | 2012-08-02 | Mibelle Ag | Cosmetic Preparation and Method for Preparing the Same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4969741B2 (ja) * | 2001-07-26 | 2012-07-04 | 株式会社ノエビア | 皮膚外用剤 |
US20120237494A1 (en) * | 2010-09-30 | 2012-09-20 | Daly Susan M | Compositions Containing Zinc PCA And Anogeissus Extract |
-
2012
- 2012-12-21 BR BR102012032898-4A patent/BR102012032898B1/pt active IP Right Grant
-
2013
- 2013-12-20 WO PCT/BR2013/000590 patent/WO2014094101A1/pt active Application Filing
- 2013-12-20 JP JP2015548116A patent/JP2016503034A/ja active Pending
- 2013-12-20 US US14/653,664 patent/US20150306010A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2808442A1 (fr) * | 2000-05-04 | 2001-11-09 | Silab Sa | Procede d'extraction d'un principe actif a partir de teguments de pomme, principe actif obtenu et composition adaptee pour lutter contre les consequences du stress oxydatif de la peau |
US20070036742A1 (en) | 2005-08-09 | 2007-02-15 | Access Business Group International Llc | Methods and compositions for modulating hair growth or regrowth |
US20120195948A1 (en) * | 2007-04-27 | 2012-08-02 | Mibelle Ag | Cosmetic Preparation and Method for Preparing the Same |
FR2916972A1 (fr) | 2007-06-07 | 2008-12-12 | Occitane Sa L | Composition cosmetique ou dermatologique a base de pomme et son utilisation. |
Non-Patent Citations (1)
Title |
---|
See also references of EP2937075A4 * |
Also Published As
Publication number | Publication date |
---|---|
JP2016503034A (ja) | 2016-02-01 |
US20150306010A1 (en) | 2015-10-29 |
BR102012032898A2 (pt) | 2014-08-26 |
BR102012032898B1 (pt) | 2019-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5798745B2 (ja) | 局所適用化粧品組成物又は医薬品組成物 | |
EP1959915B1 (en) | Mixtures comprising anthranilic acid amides and antidandruff agents as cosmetic and pharmaceutical compositions for alleviating itching | |
US9655822B2 (en) | Hydrated lamellar phases or liposomes which contain a fatty monoamine or a cationic polymer which promotes intracellular penetration, and a cosmetic or pharmaceutical composition containing same, as well as a method of screening such a substance | |
EP1991222B1 (en) | Melatonin and immunostimulating substance-based compositions | |
CN113616680B (zh) | 拟微绿球藻提取物及其应用 | |
JP2007536205A (ja) | 皮膚の老化現象抑制のための化粧品用又は皮膚薬用組成物 | |
EP2265249A1 (en) | Cosmetic compositions comprising exopolysaccharides derived from microbial mats, and use thereof | |
BRPI0816012A2 (pt) | uso de um novo agente natural em composições cosméticas | |
JPWO2004016236A1 (ja) | 化粧料 | |
JP6387219B2 (ja) | タンゲレチン及びegcgを含有する皮膚外用剤組成物 | |
JP2020529420A (ja) | ネフェリウム・ラパセウム(Nephelium lappaceum)抽出物の新規な美容的使用 | |
BR102019017062A2 (pt) | Composições tópicas compreendendo pichia anomala e retinol | |
KR20130031988A (ko) | 플로랄진세노사이드를 함유하는 피부 외용제 조성물 | |
US20100166677A1 (en) | Use of Tiliacora Triandra in Cosmetics and Compositions Thereof | |
TW201420107A (zh) | 白花蝴蝶蘭花瓣的萃取物及其製備方法與用途 | |
BR112016022734B1 (pt) | método para redução do estresse oxidativo das células, método para redução da apoptose de células induzida pelo estresse oxidativo e método para redução do fotodano das células | |
JP2015189723A (ja) | セラミド配合外用剤組成物 | |
WO2014094101A1 (pt) | Ingrediente protetor da barreira cutânea e formulação cosmética e/ou dermatológica contendo o mesmo | |
Kazmierski et al. | Plant stem cells culture—A new tool for skin protection and regeneration | |
EP2937075A1 (en) | Skin barrier protective ingredient and cosmetic and/or dermatological formulation containing the same | |
JP2008255078A (ja) | 保湿剤、抗老化剤、美白剤、抗酸化剤、痩身剤、トリートメント剤、アルギナーゼ活性促進剤及び皮膚外用剤 | |
KR20160000318A (ko) | 전나무 오일을 포함하는 화장료 조성물 | |
US20140023676A1 (en) | Cosmetic composition containing spirulina, and cosmetic treatment method | |
Ponto | Development of Novel Nanocosmeceuticals for Skin Delivery | |
JP6661292B2 (ja) | 脂質用過酸化抑制剤及び頭皮毛髪用化粧料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref document number: 2015548116 Country of ref document: JP Kind code of ref document: A |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13865534 Country of ref document: EP Kind code of ref document: A1 |
|
REEP | Request for entry into the european phase |
Ref document number: 2013865534 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2013865534 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14653664 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |